This section explores how the nuanced changes in VEGF and Glut-1 expression influenced by obesity underscore the complexity of maintaining BBB integrity and highlight the need for targeted therapeutic strategies to address these metabolic challenges. Here, SLC2A1 is linked to obesity due to melanocortin 4 receptor deficiency.